End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26.66 CNY | +0.41% | -0.41% | +27.68% |
Apr. 26 | Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 25 | Jiang Zhong Pharmaceutical Co.,Ltd Proposes Cash Dividend | CI |
Sales 2024 * | 4.95B 683M | Sales 2025 * | 5.64B 779M | Capitalization | 16.61B 2.29B |
---|---|---|---|---|---|
Net income 2024 * | 832M 115M | Net income 2025 * | 947M 131M | EV / Sales 2024 * | 3.1 x |
Net cash position 2024 * | 1.27B 176M | Net cash position 2025 * | 1.08B 148M | EV / Sales 2025 * | 2.75 x |
P/E ratio 2024 * |
20.2
x | P/E ratio 2025 * |
17.7
x | Employees | - |
Yield 2024 * |
5.16% | Yield 2025 * |
5.51% | Free-Float | 51.39% |
1 day | +0.41% | ||
1 week | -0.41% | ||
1 month | +10.62% | ||
3 months | +25.05% | ||
6 months | +34.65% | ||
Current year | +27.68% |
Managers | Title | Age | Since |
---|---|---|---|
Wen Bin Xiao
CEO | Chief Executive Officer | 44 | 21-01-11 |
Xiao Jun Li
DFI | Director of Finance/CFO | 43 | 20-03-18 |
Yang Tang
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Quan Liu
CHM | Chairman | 53 | 09-09-17 |
Na Tang
BRD | Director/Board Member | 48 | 22-11-16 |
Rong Deng
BRD | Director/Board Member | 46 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 4 M€ | -2.96% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 26.66 | +0.41% | 12,345,330 |
24-04-29 | 26.55 | -0.82% | 16,931,660 |
24-04-26 | 26.77 | -0.34% | 8,684,270 |
24-04-25 | 26.86 | -0.44% | 5,337,299 |
End-of-day quote Shanghai S.E., April 29, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+27.68% | 2.3B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- 600750 Stock